Psychedelics move from agents of rebellion towards therapeutics

Once agents of the anti-establishment, psychedelics are now moving to the commercial market, with regulatory approvals and phase 3 trials opening the door to mainstream therapeutics.
Becky McCall is a freelance journalist based in London, UK

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

doi: 10.1038/d41591-020-00001-5

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.